Randomized Clinical Comparison of the Endeavor [zotarolimus] and the Cypher [sirolimus] Coronary Stents in Non-Selected Angina Pectoris Patients

Trial Profile

Randomized Clinical Comparison of the Endeavor [zotarolimus] and the Cypher [sirolimus] Coronary Stents in Non-Selected Angina Pectoris Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Zotarolimus (Primary) ; Sirolimus
  • Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms SORT-OUT-III
  • Most Recent Events

    • 30 Aug 2017 Results of a pooled analysis of the SORT OUT III, IV, and V studies presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
    • 30 Aug 2017 Resultsof a pooled analysis of the SORT OUT III, IV, and V trials, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
    • 30 Aug 2017 Results of a 5-year pooled landmark analysis of the SORT OUT III, IV, and V trials, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top